WASHINGTON (AP) - Patients who have lost their sight due to a rare disorder may be able to regain some vision using a new implantable device that takes the place of damaged cells inside the eye.
The Food and Drug Administration on Thursday approved the Argus II Retinal Prosthesis System as the first treatment for an inherited disorder that causes the breakdown of cells in the retina, a membrane inside the eye.
FDA says that while the device will not fully restore patients' vision, "it may allow them to detect light and dark in the environment," which could help them perform daily tasks.
The system includes a small video camera and transmitter mounted on a pair of glasses. Images from the camera are processed into electronic data that is wirelessly transmitted to electrodes implanted into the patient's retina.
The FDA approved the device from Second Sight Medical Products for patients 25 years and older who have advanced retinitis pigmentosa. In people with the disease, the light-sensitive cells that line the retina gradually deteriorate, which can eventually lead to blindness.
About 100,000 people in the U.S. have the disease, though the FDA estimates fewer than 4,000 will initially receive the device under its currently approved indication. Besides the age requirement, patients must also have little to no light perception in both eyes but a prior history of being able to make out basic shapes and forms. They must also have signs of at least some remaining retinal function.
"This new surgically implanted assistive device provides an option for patients who have lost their sight to RP - for whom there have been no FDA-approved treatments," said Dr. Jeffrey Shuren, FDA's director for medical devices.
Results from a study of 30 patients showed that most were able to perform daily activities better with the implant than without it. Activities included navigating sidewalks and curbs, matching different color socks and recognizing large words or sentences.
Development of the Argus II was supported by $100 million in grant funding from the National Institutes of Health, the National Science Foundation and the Department of Energy.
Second Sight Medical Products, Inc. is based in Sylmar, Calif.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Should a doctor be able to help a patient end his or her life? It's a controversial question that has been debated across the U.S. and on Wednesday, it was New Mexico's turn.
Investigators called it one of the worst animal cruelty cases they've seen. Now, more than a month after dozens of animals were seized from a property in San Miguel County, the owners are facing jail time.
The Office of the Medical Investigator identified the two victims in Sunday's plane crash which happened just south of the airport.
Gov. Susana Martinez is ordering that flags be flown at half-staff on Thursday to honor a Sandoval County sheriff's sergeant who died after being struck by a vehicle during a snow storm.
While Bernalillo County leaders continue to look for a way out of a risky investment plan that’s already cost taxpayers hundreds of thousands of dollars, the Treasurer’s Office insists it has an exit strategy well in hand.
A woman has pleaded guilty to embezzling nearly $9,000 that was supposed to be going to kids.